What Researchers Did
Researchers retrospectively analyzed 80 patients with intracranial venous thrombosis, comparing outcomes between those treated with low molecular weight heparin alone and those receiving additional hyperbaric oxygen.
What They Found
The group treated with low molecular weight heparin and hyperbaric oxygen showed significantly lower National Institutes of Health Stroke Scale (NIHSS) scores, D-dimer, fibrinogen, TNF-α, and C-reactive protein levels after treatment compared to the control group. This group also had a significantly higher overall response rate, with no significant difference in adverse effects.
What This Means for Canadian Patients
Canadian patients with intracranial venous thrombosis might benefit from a combined therapy of low molecular weight heparin and hyperbaric oxygen, potentially leading to improved neurological function and reduced inflammation. This approach could offer better treatment efficacy and quality of life without increasing the risk of side effects.
Canadian Relevance
This study was conducted in China and does not have a direct Canadian connection or specific Canadian relevance.
Study Limitations
The retrospective design, single-center data, and relatively small sample size limit the generalizability of these findings.